Sunday, September, 15, 2019 05:51:22

Surgical Sealant and Adhesive Market size is projected to experience significant growth from 2019 to 2025.Rising burden of chronic diseases has resulted in increased number of surgeries over the last few years. According to International Diabetes Federation, around 425 million adults were living with diabetes in 2017 and the number is estimated to reach 629 million in upcoming years. Increased blood glucose level can lead to serious heart disease and chronic wounds. Thus, increasing use of surgical sealants and adhesives to treat surgical incision will drive the industry growth.

Rising preference for surgical sealants and adhesives will drive the industry growth. Traditional method such as stapler and sutures can cause surgical marks and fluid leakages. Biological sealants help in wound healing process and eliminate the need of sutures by forming chemical bonds to stop blood oozing and fluid leakage after surgery. Newly developed biological and synthetic adhesives provide numerous advantages such as safety, efficacy and durability. Thus, patients and healthcare experts prefer surgical sealants that will augment the business growth.

Request In-depth table of contents @

Natural surgical sealant segment will show lucrative growth during the forecast timeframe. Natural surgical sealant is derived from biological agents that act as a temporary skin during the healing process. Biological sealants have more intact extracellular matrix structure that allow construction of natural dermis than synthetic sealants. Biological sealants are useful in reconstructive and plastic surgeries for surgical incision closure as they are re-absorbable and have low chances of bacterial infections. Growing adoption of natural sealants in surgical process will further boost the business growth.

Cardiovascular surgery segment will witness significant growth over the analysis timeframe. Rising burden of cardiovascular diseases worldwide will create numerous growth opportunities for surgical sealants and adhesives. According to WHO, CVD is one of the leading causes if death, resulting in around 17.9 million cardiac deaths every year. Changing lifestyle habits along with stress and hypertension increases the risk of CVD. According to Texas heart institute, in the U.S., surgeons perform around 5,00,000 bypass surgeries every year. Thus, rising number of cardiovascular surgeries will thus augment the segmental growth.

Make Inquiry about this report @

Hospitals segment is estimated to witness substantial growth during the forthcoming years. Increasing patient inflow in hospitals for surgical process will positively impact segmental growth. Availability of advanced surgical equipment, staffing & training and availability of comparatively low-cost surgical sealants and adhesives will offer lucrative growth opportunities over the forecast period.

U.S. dominated the North America surgical sealant and adhesive market in 2018. Rising prevalence of chronic disease in the region due to lifestyle changes will spur the surgical sealants and adhesive market. According to CDC, around 30.3 million people have diabetes in the U.S. Thus, rising patient pool in the country will drive the segmental growth. Moreover, presence of sophisticated healthcare infrastructure coupled with skilled professional will further augment the business growth.

Eminent industry players in surgical sealant and adhesive market include Johnson & Johnson, Baxter International, Integra LifeSciences, Medtronic, CryoLife, B. Braun Melsungen AG, C. R. Bard, Sealantis, Sanofi and Cohera Medical. Industry players focus on innovative product launch as their main strategies as well as mergers and acquisitions to expand existing product portfolio and capture high market share. For instance, in March 2018, Baxter acquired RECOTHROM and PREVELEAK to broaden its surgical sealant portfolio.

Company Profiles:

  • Johnson & Johnson
  • Baxter International
  • Integra LifeSciences
  • Medtronic
  • CryoLife
  • B. Braun Melsungen AG
  • C. R. Bard
  • Sealantis
  • Sanofi
  • Cohera Medical